Paradigm Biocapital Advisors LP

Holdings History for Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

Symbol: JANX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 3.52M shares
Security Ownership: 6%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in Janux Therapeutics, Inc. Common Stock, par value $0.001 per share (JANX)

2025-02-14 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.52M shares of Janux Therapeutics, Inc. Common Stock, par value $0.001 per share (JANX). This represents 6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Paradigm BioCapital Advisors LP	6%		$94.9M	3.52M			$27.00	13G/A	12/31/2024	14 Feb 2025 16:41:39

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	6.55%	+2.08%	$188M	3.52M	+1,115,412	+46.5%	$53.54	Q4 2024
9/30/2024	3.82%	+1.33%	$109M	2.4M	+836,122	+53.4%	$45.43	Q3 2024
6/30/2024	2.51%	+2.33%	$65.5M	1.56M	+1,564,452	NEW	$41.89	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.